Am J Surg. 2013 Apr;205(4):483.Pterostilbene and its emerging
antineoplastic effects: a prospective treatment option for systemic
malignancies. Kapoor S.
7)
http://www.bioportfolio.com/resources/pmarticle/383498/Chemopreventive-Effects-of-Pterostilbene-on-Urethane-Induced-Lung-Carcinogenesis-in-Mice-via.html
Chemopreventive Effects of Pterostilbene on Urethane-Induced Lung
Carcinogenesis in Mice via the Inhibition of EGFR-Mediated Pathways and
the Induction of Apoptosis and Autophagy. Department of Environmental
and Occupational Health, National Cheng Kung University Medical College ,
Tainan, Taiwan.
Journal of agricultural and food chemistry
The aim of this study is to investigate the chemopreventive effects of pterostilbene in urethane-induced murine lung tumors.
Pretreatment with pterostilbene at 50 or 250 mg/kg significantly reduced tumor multiplicity by 26 and 49%, respectively. Pterostilbene also
significantly inhibited tumor volume by 25 and 34% and decreased the tumor burden per mouse by 45 and 63%, respectively.
2012
8)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276376/
http://www.ncbi.nlm.nih.gov/pubmed/22347521
Am J Transl Res. 2012;4(1):44-51. Epub 2012 Jan 5.
Pterostilbene simultaneously induces apoptosis, cell cycle arrest and
cyto-protective autophagy in breast cancer cells.Wang Y, Ding L, Wang X,
Zhang J, Han W, Feng L, Sun J, Jin H, Wang XJ.
As a nature phytoalexin found in grapes, resveratrol has been
proposed as a potential drug for cancer chemoprevention and treatment.
However, its poor bioavailability limits its potential clinical
application. Pterostilbene, the natural dimethylated analog of
resveratrol with greater bioavailability, was confirmed to inhibit tumor
growth both in vivo and in vitro, demonstrating its potential for
further clinical application.
In the current study, we found that pterostilbene could markedly inhibit the growth of two independent breast cancer cell lines.
Both apoptosis and cell cycle arrest as well as the inhibition of wnt
singling was induced by pterostilbene. The dominant-active mutant of
ß-catenin could reverse the growth inhibitory effect of pterostilbene,
indicating that the inhibition of wnt signaling is important to the
growth inhibitory effect of pterostilbene. Interestingly,
pterostilbene
induced autophagy and blockage of autophagy augmented
pterostilbene-induced growth inhibition, suggesting that the combination
of autophagy inhibitors with pterostilbene and other
therapeutics such as endocrine drugs could serve as a new and promising
strategy for the treatment of breast cancer cells.
2012
9)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434130/
http://www.ncbi.nlm.nih.gov/pubmed/22957077
PLoS One. 2012;7(9):
Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane
permeabilization-dependent mechanism. Mena S, Rodríguez ML, Ponsoda X,
Estrela JM, Jäättela M, Ortega AL. Source Green Molecular, Valencia,
Spain.
The phenolic phytoalexin resveratrol is well known for its
health-promoting and anticancer properties. Its potential benefits are,
however, limited due to its low bioavailability.
Pterostilbene, a natural dimethoxylated analog of resveratrol, presents higher anticancer activity than resveratrol. The mechanisms by which this polyphenol acts against cancer cells are, however, unclear.
Here,
we show that pterostilbene effectively inhibits cancer cell growth and
stimulates apoptosis and autophagosome accumulation in cancer cells of
various origins. However, these mechanisms are not determinant in cell demise.
Pterostilbene promotes cancer cell death via a
mechanism involving lysosomal membrane permeabilization.
Different grades of susceptibility were observed among the different
cancer cells depending on their lysosomal heat shock protein 70 (HSP70)
content, a known stabilizer of lysosomal membranes. A375 melanoma and
A549 lung cancer cells with low levels of HSP70 showed high
susceptibility to pterostilbene, whereas HT29 colon and MCF7 breast
cancer cells with higher levels of HSP70 were more resistant. Inhibition
of HSP70 expression increased susceptibility of HT29 colon and MCF7
breast cancer cells to pterostilbene.
Our data indicate that lysosomal membrane permeabilization is the main cell death pathway triggered by pterostilbene.
2013
10)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643961/
http://www.ncbi.nlm.nih.gov/pubmed/23671619
PLoS One. 2013 May 3;8(5) Pterostilbene Exerts Antitumor Activity via
the Notch1 Signaling Pathway in Human Lung Adenocarcinoma Cells. Yang
Y, Yan X, Duan W, Yan J, Yi W, Liang Z, Wang N, Li Y, Chen W, Yu S, Jin
Z, Yi D. Department of Cardiovascular Surgery, Xijing Hospital, The
Fourth Military Medical University, Xi’an City, China.
In this study, we investigated the antitumor activity of PTE against
human lung adenocarcinoma in vitro and in vivo and explored the role of
the Notch1 signaling pathway in this process.
PTE treatment resulted in a dose- and time-dependent decrease in the viability of A549 cells. Additionally,
PTE exhibited strong antitumor activity, as evidenced not only by a
reduced mitochondrial membrane potential (MMP) and a decreased
intracellular glutathione content but also by increases in the apoptotic
index and the level of reactive oxygen species (ROS).
Furthermore, PTE treatment induced the activation of the Notch1
Intracellular Domain (NICD) protein and activated Hes1. DAPT (a gamma
secretase inhibitor) and Notch1 siRNA prevented the induction of NICD
and Hes1 activation by PTE treatment and sensitized the cells to PTE
treatment. The down-regulation of Notch signaling also prevented the
activation of pro-survival pathways (most notably the PI3K/Akt pathway)
after PTE treatment. In summary, lung adenocarcinoma cells may enhance
Notch1 activation as a protective mechanism in response to PTE
treatment.
2010
11)
http://www.ncbi.nlm.nih.gov/pubmed/20031172
J Surg Res. 2010 Jun 15;161(2):195-201.
Pterostilbene inhibits breast cancer in vitro through mitochondrial
depolarization and induction of caspase-dependent apoptosis. Alosi JA,
McDonald DE, Schneider JS, Privette AR, McFadden DW. University of
Vermont, Burlington, Vermont, USA.
Epidemiologic studies suggest that diets high in fruits and
vegetables reduce cancer risk. Resveratrol, a compound present in
grapes, has been shown to inhibit a variety of primary tumors.
Pterostilbene, an analogue of resveratrol found in blueberries,
has both antioxidant and antiproliferative properties. We hypothesized
that pterostilbene would induce apoptosis and inhibit breast cancer cell
growth in vitro.
METHODS:
Breast cancer cells were treated with graduated doses of pterostilbene.
Cell viability was measured by MTT assay. Apoptosis was evaluated via
DNA fragmentation assay and TUNEL assay. Apo-ONE caspase-3/7 assay was
used to evaluate caspase activity. Flow cytometry was used to evaluate
mitochondrial depolarization, superoxide formation, and cell cycle.
Student’s t-test and two-way ANOVA with Bonferroni posttests were
utilized for statistical analysis.
RESULTS: Pterostilbene decreased breast cancer cell viability in a
concentration- and time-dependent manner. Pterostilbene treatment
increased caspase-3/7 activity and apoptosis in both cell lines.
Caspase-3/7 inhibitors completely reversed pterostilbene’s effects on
cell viability. Pterostilbene treatment triggered mitochondrial
depolarization, increased superoxide anion, and caused alteration in
cell cycle.
CONCLUSIONS: Pterostilbene treatment inhibits the growth of breast
cancer in vitro through caspase-dependent apoptosis. Mitochondrial
membrane
depolarization and increased superoxide anion may contribute to the
activation downstream effector caspases. Caspase inhibition leads to
complete reversal of pterostilbene’s effect on cell viability. Further
in vitro mechanistic studies and in vivo experiments are warranted to
determine its potential for the treatment of breast cancer.
2006
12)
Pharmacometrics_of_Pterostilbenes_Curr_Clin_Pharmacol_2006_Davies
Curr Clin Pharmacol. 2006 Jan;1(1):81-101.
Pharmacometrics of stilbenes: seguing towards the clinic.
Roupe KA, Remsberg CM, Yáñez JA, Davies NM.
Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Pullman, Washington 99164-6534, USA.
Stilbenes are small molecular weight (approximately 200-300 g/mol),
naturally occurring compounds and are found in a wide range of plant
sources, aromatherapy products, and dietary supplements. These molecules
are synthesized via the phenylpropanoid pathway and share some
structural similarities to estrogen.
Upon environmental threat,
the plant host activates the phenylpropanoid pathway and stilbene
structures are produced and subsequently secreted. Stilbenes act as
natural protective agents to defend the plant against viral and
microbial attack, excessive ultraviolet exposure, and disease.
One stilbene, resveratrol, has been extensively studied and has been
shown to possess potent anti-cancer, antiinflammatory and anti-oxidant
activities. Found primarily in the skins of grapes,
resveratrol is synthesized by Vitis vinifera grapevines in response to fungal infection or other environmental stressors.
Considerable research showing resveratrol to be an attractive candidate
in combating a wide variety of cancers and diseases has fueled interest
in determining the disease-fighting capabilities of other structurally
similar stilbene compounds. The purpose of this review is to describe
four such structurally
similar stilbene compounds, piceatannol, pinosylvin, rhapontigenin, and pterostilbene and detail some current pharmaceutical research and highlight their potential clinical applications.
13)
Pterostilbene_suppresses_aberrant_crypt_colon_carcinogenesis
Clin Cancer Res. 2007 Jan 1;13(1):350-5.
Pterostilbene, an active constituent of blueberries, suppresses aberrant
crypt foci formation in the azoxymethane-induced colon carcinogenesis
model in rats.
Suh N, Paul S, Hao X, Simi B, Xiao H, Rimando AM, Reddy BS.
Source Department of Chemical Biology, Ernest Mario School of Pharmacy,
Rutgers, The State University of New Jersey, Piscataway, New Jersey
08854, USA.
Epidemiologic studies have linked the consumption of fruits and
vegetables to reduced risk of several types of cancer. Laboratory animal
model studies have provided evidence that stilbenes, phenolic compounds
present in grapes and blueberries, play a role in inhibiting the risk
of certain cancers. Pterostilbene, a naturally occurring stilbene from
blueberries, was tested for its preventive activity against colon
carcinogenesis.
EXPERIMENTAL DESIGN: Experiments were designed to study the inhibitory effect of pterostilbene against the formation of
azoxymethane-induced colonic aberrant crypt foci (ACF) preneoplastic lesions in male F344 rats.
Beginning at 7 weeks of age, rats were treated with azoxymethane (15
mg/kg body weight s.c., once weekly for 2 weeks). One day after the
second azoxymethane treatment, rats were fed experimental diets
containing
0 or 40 ppm of pterostilbene. At 8 weeks
after the second azoxymethane treatment, all rats were sacrificed, and
colons were evaluated for ACF formation and for inhibition of inducible
nitric oxide synthase (iNOS) and proliferating cell nuclear antigen.
Effects on mucin MUC2 were also determined.
RESULTS: Administration of pterostilbene for 8 weeks significantly suppressed azoxymethane-induced formation of ACF (
57% inhibition, P < 0.001) and multiple clusters of aberrant crypts (
29% inhibition,
P < 0.01). Importantly, dietary pterostilbene also suppressed
azoxymethane-induced colonic cell proliferation and iNOS expression.
Inhibition of iNOS expression by pterostilbene was confirmed in cultured
human colon cancer cells.
CONCLUSIONS: The results of the present study suggest that
pterostilbene, a compound present in blueberries, is of great interest
for the prevention of colon cancer.
14)
Pharmacometrics_of_pterostilbene_Phytother_Res_2008
Phytother Res. 2008 Feb;22(2):169-79. Pharmacometrics of pterostilbene:
preclinical pharmacokinetics and metabolism, anticancer,
antiinflammatory, antioxidant and analgesic activity. Remsberg CM,
Yáñez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. Department of
Pharmaceutical Sciences, College of Pharmacy, Washington State
University Pullman, Washington 99164-6534, USA.
The present study evaluated the preclinical pharmacokinetics and
pharmacodynamics of trans-pterostilbene, a constituent of some plants.
Right jugular vein cannulated male Sprague-Dawley rats were dosed i.v.
with 20 mg/kg of pterostilbene and samples were analysed by the reverse
phase HPLC method. Serum AUC, serum t(1/2), urine t(1/2), Cl(total) and
Vd(beta) were 17.5 +/- 6.6 microg/h/mL, 1.73 +/- 0.78 h, 17.3 +/- 5.6 h,
0.960 +/- 0.025 L/h/kg and 2.41 +/- 1.13 L/kg (mean +/- SEM),
respectively. A pterostilbene glucuronidated metabolite was detected in
both serum and urine. The in vitro metabolism in rat liver microsomes
furthermore suggests phase II metabolism of pterostilbene.
Pterostilbene
demonstrated concentration-dependent anticancer activity in five cancer
cell lines (1-100 microg/mL). An in vitro colitis model showed
concentration-dependent suppression of PGE(2) production in the media of
HT-29 cells. Antiinflammatory activity was examined by inducing
inflammation in canine chondrocytes followed by treatment with
pterostilbene (1-100 microg/mL). The results showed decreased
levels of MMP-3, sGAG and TNF-alpha compared with control levels.
Pterostilbene exhibited concentration-dependent antioxidant capacity
measured by the ABTS method. Pterostilbene increased the latency period
to response in both tail-flick and hot-plate analgesic tests.
15)
Resveratrol_derivatives_cancer_Drug_Discov_Today_2010_Fulda
Drug Discov Today. 2010 Sep;15(17-18):757-65.
Resveratrol and derivatives for the prevention and treatment of cancer.
Fulda S. Institute for Experimental Cancer Research in Pediatrics,
Goethe-University, D-60528 Frankfurt, Germany.
There are several natural derivatives of resveratrol that are
structurally similar to resveratrol and are also present in food. Such
resveratrol derivatives might provide promising tools as cancer
chemopreventive agents, as well as cancer therapeutics in the prevention
and treatment of cancer. This review provides an overview of key
derivatives of resveratrol as cancer therapeutics.
16)
http://www.hindawi.com/journals/ecam/2011/562187/
Evidence-Based Complementary and Alternative Medicine Volume 2011
(2011), Suppression of Heregulin-β1/HER2-Modulated Invasive and
Aggressive Phenotype of
Breast Carcinoma by
Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation
Min-Hsiung Pan,1 Ying-Ting Lin,2 Chih-Li Lin,3 Chi-Shiang Wei,2
Chi-Tang Ho,4 and Wei-Jen Chen21Department of Seafood Science, National
Kaohsiung Marine University, Nan-Tzu, Kaohsiung, Taiwan 2Department of
Biomedical Sciences, Chung Shan Medical University, No. 110, Section 1,
Chien-Kuo N. Road, Taichung 402, Taiwan 3Institute of Medicine, Chung
Shan Medical University, Taichung 402, Taiwan 4Department of Food
Science, Cook College, Rutgers University, New Brunswick, NJ, USA
17)
Pterostilbene_apoptosis_ leukemia
http://www.ncbi.nlm.nih.gov/pubmed/23264221
Folia Histochem Cytobiol. 2012;50(4):574-80.
Pterostilbene induces cell cycle arrest and apoptosis in MOLT4 human leukemia cells.
Siedlecka-Kroplewska K, Jozwik A, Kaszubowska L, Kowalczyk A, Boguslawski W.
Department of Histology, Medical University of Gdansk, Gdansk, Poland.
Pterostilbene, a polyphenolic compound present in grapes and other
fruits, has been demonstrated to inhibit growth and induce apoptosis and
autophagy in some cancer cell types. We found that pterostilbene at the
IC(90) concentration of 44 µM inhibited proliferation and induced
apoptosis in MOLT4 human leukemia cells. Treatment with pterostilbene
resulted in a transient accumulation of cells in the G(0)/G(1)-cell
cycle phase followed by the S-phase arrest.
Pterostilbene-induced
apoptotic death of MOLT4 cells was mediated by caspase-3 activation and
was accompanied by the disruption of mitochondrial membrane potential, phosphatidylserine externalization and internucleosomal DNA fragmentation.
Our
results suggest that pterostilbene could serve as a potential
additional chemotherapeutic agent for the treatment of leukemia.
commercial product monograph
18)
Natural-Pterostilbene “NATURAL PTEROSTILBENE.” by MAJEED, MUHAMMED.
19)
http://clincancerres.aacrjournals.org/content/16/24/5942.long
Clin Cancer Res. 2010 Dec 15;16(24):5942-8.
Resveratrol: challenges in translation to the clinic–a critical
discussion.Subramanian L, Youssef S, Bhattacharya S, Kenealey J, Polans
AS, van Ginkel PR.Department of Ophthalmology and Visual Sciences, Eye
Research Institute, and Carbone Cancer Center, University of Wisconsin,
Madison, Wisconsin 53792, USA.
Abstract
Low cancer survival rates and the serious side effects often
associated with current chemotherapeutics highlight the need for new and
effective nontoxic anticancer agents. Since 1997 when Jang and
colleagues first described resveratrol’s ability to inhibit
carcinogenesis, it has consistently proven effective at tumor inhibition
in diverse human cancer models. This finding has raised the hope that
resveratrol would pioneer a novel class of nontoxic chemotherapeutics.
As a consequence of initial basic and preclinical studies, resveratrol
is now being extensively promoted in the unregulated nutraceutical
sector. However, some fundamental aspects of resveratrol’s action need
to be understood before it can be developed into a clinically viable
anticancer drug. These areas pertain to the key mechanism(s) by which
resveratrol potentiates its antitumor effects. Current research suggests
that these mechanisms might be through novel pathways, requiring an
understanding of cellular uptake, sentinel targets, and in vivo
biological networks. The metabolism of resveratrol and its
bioavailability also warrant further consideration in light of recent in
vitro and in vivo studies. Finally, we need to appreciate the sorts of
information about resveratrol that may translate between different
disease entities. We present a critical discussion of these issues and
suggest important experiments that could pave the way to the successful
translation of resveratrol to the clinic.
20)
http://www.ncbi.nlm.nih.gov/pubmed/22842666
Food Funct. 2012 Nov;3(11):1185-94. Pterostilbene, a natural analogue of
resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene
(DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-
induced mouse skin carcinogenesis.
Tsai ML, Lai CS, Chang YH, Chen WJ, Ho CT, Pan MH.Department of Seafood
Science, National Kaohsiung Marine University, Nan-Tzu, Kaohsiung 811,
Taiwan. mltasi@mail.nkmu.eud.tw
Abstract
We reported previously that pterostilbene, a natural analogue of
resveratrol from blueberries, strongly suppressed
lipopolysaccharide-induced up-expression of inducible NO synthase (iNOS)
and cyclooxygenase-2 (COX-2) in murine macrophages. In this study, we
further investigated pterostilbene’s molecular mechanism of action and
its anti-tumor properties. Pretreatment with pterostilbene has resulted
in the reduction of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced
nuclear translocation of the nuclear factor-κB (NFκB) subunits.
Pterostilbene also reduced TPA-induced phosphorylation of IκBα and p65
and caused subsequent degradation of IκBα. Moreover, pterostilbene
markedly suppressed TPA-induced activation of extracellular
signal-regulated kinase (ERK)1/2, p38 mitogen-activated protein kinase
(MAPK), c-Jun N-terminal kinase (JNK)1/2, phosphatidylinositol 3-kinase
(PI3K) and Akt, which are upstream of NFκB and activator protein 1
(AP-1). Furthermore, pterostilbene significantly inhibited
7,12-dimethylbenz[a]anthracene (DMBA)/TPA-induced skin tumor formation
measured by the tumor multiplicity of papillomas at 20 weeks. The
presented data has, for the first time, revealed that pterostilbene is
an effective anti-tumor agent that functions by downregulating
inflammatory iNOS and COX-2 gene expression in mouse skin. It is
suggested that pterostilbene is a novel functional agent capable of
preventing inflammation-associated tumorigenesis.
Jeffrey Dach MD
Offices of Willow Grove
7450 Griffin Road, Suite 190
Davie, Fl 33314